Invention Grant
- Patent Title: Anti-human tenascin monoclonal antibody
- Patent Title (中): 抗人腱生蛋白单克隆抗体
-
Application No.: US12232431Application Date: 2008-09-17
-
Publication No.: US08048417B2Publication Date: 2011-11-01
- Inventor: De Santis Rita , Anastasi Anna Maria
- Applicant: De Santis Rita , Anastasi Anna Maria
- Applicant Address: IT Rome
- Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- Current Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- Current Assignee Address: IT Rome
- Agency: Lucas & Mercanti, LLP
- Main IPC: C07K16/00
- IPC: C07K16/00 ; G01N33/53 ; A61K39/395
Abstract:
A novel anti-human tenascin ST2146 monoclonal antibody is described endowed with high affinity with the native antigen and high tumor selectivity. The cST2146 hybridoma is stably producing the antibody in high density culture conditions and is suitable for the industrial development of ST2146-based products. ST2146 exhibits properties exploitable for both therapeutic and diagnostic applications.
Public/Granted literature
- US20110020219A1 Anti-human tenascin monoclonal antibody Public/Granted day:2011-01-27
Information query
